ArticleNature communications2023
Author Correction: CD98hc is a target for brain delivery of biotherapeutics.
Abstract readPublished Erratum
In one paragraph
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
50 authors.
Kylie S Chew *Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Robert C Wells *Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Arash MoshkforoushDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Darren ChanDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kendra J LechtenbergDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Hai L TranDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-3715-8111
Johann ChowDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0009-0001-8170-6392
Do Jin KimDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Yaneth Robles-ColmenaresDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Devendra B SrivastavaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Raymond K TongDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Mabel TongDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kaitlin XaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Alexander YangDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Yinhan ZhouDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Padma AkkapeddiDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Lakshman AnnamalaiDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kaja BajcDepartment of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.
Marie BlanchetteDepartment of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.
Gerald Maxwell CherfDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Timothy K EarrDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Audrey GillDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
David HuynhDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
David JoyDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0001-9941-9538
Kristen N KnightDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Diana LacDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Amy Wing-Sze LeungDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Katrina W LexaDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Nicholas P D LiauDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Isabel BecerraDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Mario MalfavonDepartment of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.
Joseph McInnesDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Hoang N NguyenDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0001-6608-7581
Edwin I LozanoDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Michelle E PizzoDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-4219-5996
Elysia RocheDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Patricia SacayonDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Meredith E K CalvertDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Richard DanemanDepartment of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.
Mark S DennisDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Joseph DuqueDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Kapil GadkarDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Joseph W LewcockDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.ORCID http://orcid.org/0000-0003-3012-7881
Cathal S MahonDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
René MeisnerDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Hilda SolanoyDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Robert G ThorneDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Ryan J WattsDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.
Y Joy Yu ZucheroDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com.
Mihalis S KariolisDenali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.ORCID http://orcid.org/0000-0003-2067-4013
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.